PD-1 blockade enhances the vaccination-induced immune response in glioma-Reference-Cited by-同舟云学术

PD-1 blockade enhances the vaccination-induced immune response in glioma

Published:2016-07-07 Issue:10 Volume:1 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Antonios Joseph P.,Soto Horacio,Everson Richard G.,Orpilla Joey,Moughon Diana,Shin Namjo,Sedighim Shaina,Yong William H.,Li Gang,Cloughesy Timothy F.,Liau Linda M.,Prins Robert M.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Molecular and Genomic Alterations in Glioblastoma Multiforme

2. Glioblastoma survival in the United States before and during the temozolomide era

3. Primary brain tumors in adults;Chandana;Am Fam Physician,2008

4. Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

5. Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies;International Journal of Molecular Sciences;2024-07-09

2. TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors;Cancer Immunology, Immunotherapy;2024-07-02

3. Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products;Cytotherapy;2024-07

4. The immunosuppressive landscape in tumor microenvironment;Immunologic Research;2024-05-01

5. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10